Top 3 Healthcare stocks with upto 31% Price Gains in Jan-Mar 2024

During the first quarter of 2024, a number of stocks belonging to pharma & healthcare sector witnessed steep rise in the share prices. There were four listed stocks which delivered price gains of more than 25% for the first quarter. All the stocks were listed on NYSE and are part of S&P500 index. However, top 3 healthcare stocks delivered price gains ranging from 26%-31% in Jan-Mar.

Eli Lilly & Co topped the chart followed by Organon & Co and Edwards Lifesciences Corp.

Eli Lilly (LLY) delivered 31% price gains during the Jan-Mar period as its share price rose from $592 on 2^nd Jan to $777 on 28^th Mar. Eli Lilly  stock had already scaled to $782 in the beginning on March but since then stock witnessed correction in its stock prices during the month of March when it declined by -1%.

Organon & Co (OGN) was the cheapest stock in the list of top performers. Organon & Co is a market player in women’s healthcare products which focuses on female fertility and life style disease solutions.  OGN started the year at $14.7 and rose to $18.8 by end of March delivering price gains of 28% for the first quarter. The stock performed well during the month of March as its share price rose by 7% for the month.

Edwards Lifesciences Corp (EW) was the third most well performed healthcare stock of the first quarter of 2024. The stock delivered 26% price gains as it rose from $75.5 to $95.5 by end of March. The stock maintained its upward momentum as it gained 12% in the march itself. Edwards is medical devices manufacturer with focus on cardiovascular surgical solutions and critical lifecare technologies.  

Table: Top Healthcare Stocks